REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Spain limits AstraZeneca coronavirus vaccine to over 60-year olds

Wed, 07th Apr 2021 23:14

(Recasts to focus on AstraZeneca)

MADRID, April 7 (Reuters) - Spain will only give
AstraZeneca's coronavirus vaccine to people over 60 years old
after European and British regulators found a potential link
between the shot and rare brain blood clots.

"The vaccination strategy is changing and from tomorrow only
over 60-year-olds will be vaccinated with AstraZeneca," Health
Minister Carolina Darias told a news conference late on
Wednesday following a meeting of regional health chiefs.

Darias said a decision would be taken on Thursday on whether
to administer the second round of the vaccine to people who had
already received their first dose.

The European Medicines Agency announced earlier it had
reports of 169 cases of the rare clotting disorder out of 34
million doses administered within Europe, roughly one for every
100,000 people under 60 vaccinated. Most occurred in women under
60 and within two weeks of injection. [nL1N2M01J1

Maria Jesus Lamas, director of Spain's drug regulator, said
that number was higher than expected, though very small:
"Despite the rarity of these side effects, the modification to
the technical guidance is important," Lamas said.

A summit of European Union health ministers failed to agree
on common guidance for the vaccine and the EMA said countries
should set their own regulations.

Spain's decision follows Italy recommending the shot only
for those over 60 and Britain said people under 30 should get an
alternative.

People lining up for a shot in Madrid earlier on Wednesday
vented frustration at constantly changing guidance for the
vaccine, which is subject to a patchwork of different rules
governing its use.

"Today has been a very distressing day because of all the
news coming from the European Medicines Agency," said Carmen
Ruiz after coming out of Atletico Madrid's Wanda football
stadium, now converted into a vaccine centre.

Though Spain is faring better than neighbouring France,
where rampant infections have pushed hospital admittance rates
to near five-month highs, the daily caseload has been increasing
for three weeks.

The health ministry registered 8,788 new cases, bringing the
total to 3.33 million. The death toll rose by 126 to 76,037.

Wary that increased social contact over Easter could trigger
a full-blown fourth wave, authorities in Catalonia, the Basque
Country and Aragon imposed fresh restrictions on movement.

(Reporting by Clara-Laeila Laudette, Guillermo Martinez, Elena
Rodriguez, Nathan Allen and Joan Faus, editing by Andrei Khalip
and Grant McCool)

More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.